http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-059031-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351 |
filingDate | 2007-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34b9db8cb7add98445191ae7148e0100 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_181a69237f31419ec20a486f847332fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6643ee6c658d3ad00b174ec6d29890c |
publicationDate | 2008-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AR-059031-A1 |
titleOfInvention | COMBINATION OF TRIAZINE DERIVATIVES AND INHIBITORS OF THE HMG- COA REDUCTASA |
abstract | Claim 1: Pharmaceutical composition comprising, as active ingredient: i) an HMG-CoA reductase inhibitor, ii) a triazine derivative of the formula (1) wherein: R1, R2, R3 and R4 are selected as independent between the following groups: H; -C1-20 alkyl optionally substituted with halogen, C1-5 alkyl, C1-5 alkoxy, C3-8 cycloalkyl; C2-20 alkenyl optionally substituted with halogen, C1-5 alkyl or C1-5 alkoxy; -C2-20alkynyl optionally substituted with halogen, C1-5 alkyl or C1-5 alkoxy; -C3-8cycloalkyl optionally substituted with C1-5 alkyl or C1-5 alkoxy; -C3-8 heterocycloalkyl with one or more heteroatoms selected from N, O and S and optionally substituted with C1-5 alkyl or C1-5 alkoxy; -C6-14 alkyl C1-20 alkyl optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6-14 aryloxy, C6-14 aryl C1- alkoxy 5, cyano, trifluoromethyl, carboxy, carboxymethyl or carboxy ethyl; -C6-14 aryl optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6-14 aryloxy, C6-14 aryl C1-5 alkoxy, cyano , trifluoromethyl, carboxy, carboxymethyl or carboxy ethyl; C1-13 heteroaryl with one or more heteroatoms selected from N, O and S and optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, aryloxy C6-14, C6-14 aryl C1-5 alkoxy, cyano, trifluoromethyl, carboxyl, carboxymethyl or carboxy ethyl; R1 and R2, on the one hand, and R3 and R4, on the other hand, can form with the nitrogen atom a ring of n-members (n is between 3 and 8) that optionally contains one or more heteroatoms selected from N, O and S and may be substituted by one or more of the following groups: amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6-14 aryloxy, C6 aryl -14-C1-5 alkoxy, cyano, trifluoromethyl, carboxyl, carboxymethyl or carboxyethyl; R5 and R6 are independently selected from the following groups: -H; - C1-20 alkyl optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6-14 aryloxy, C6-14 aryl C1-5 alkoxy, cyano , trifluoromethyl, carboxy, carboxymethyl or carboxy ethyl; - C2-20 alkenyl optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6-14 aryloxy, C6-14 aryl C1-5 alkoxy, cyano , trifluoromethyl, carboxy, carboxymethyl or carboxy ethyl; C2-20 -alkynyl optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6-14 aryloxy, C6-14 aryl C1-5 alkoxy, cyano , trifluoromethyl, carboxy, carboxymethyl or carboxy ethyl; -C3-8cycloalkyl optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6-14 aryloxy, C6-14 aryl C1-5 alkoxy, cyano , trifluoromethyl, carboxy, carboxymethyl or carboxy ethyl; -C3-8 heterocycloalkyl with one or more heteroatoms selected from N, O and S and optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, aryloxy C6-14, C6-14 aryl C1-5 alkoxy, cyano, trifluoromethyl, carboxyl, carboxymethyl or carboxy ethyl; -C6-14 aryl optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6-14 aryloxy, C6-14 aryl C1-5 alkoxy, cyano , trifluoromethyl, carboxy, carboxymethyl or carboxy ethyl; C1-13 heteroaryl with one or more heteroatoms selected from N, O and S and optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6 aryloxy -14, C6-14 aryl C1-5 alkoxy, cyano, trifluoromethyl, carboxy, carboxymethyl or carboxy ethyl; C6-14 aryl C1-5 alkyl optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6-14 aryloxy, C6-14 aryl C1-5 alkoxy , cyano, trifluoromethyl, carboxy, carboxymethyl or carboxymethyl, R5 and R6 can form with the carbon atom to which a ring of m members (m is between 3 and 8) is attached which optionally contains one or more heteroatoms selected from N, O and S and may be substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1-5 alkylamino, C6-14 aryloxy, C6-14 aryl C1-5 alkoxy, cyano, trifluoromethyl, carboxyl, carboxymethyl or carboxyethyl, or they can form a C10-30 polycyclic residue optionally substituted with amino, hydroxyl, thio, halogen, C1-5 alkyl, C1-5 alkoxy, C1-5 alkylthio, C1 alkylamino with the carbon atom -5, C6-14 aryloxy, C6-14 aryl C1-5 alkoxy, cyano, trifluoromethyl, carboxy, carboxymethyl or carboxy ethyl, R5 and R6 together may also n representing group = O or = S, the nitrogen atom of a heterocycloalkyl or heteroaryl group may be substituted with a C1-5 alkyl, C3-8 cycloalkyl, C6-14 aryl, C6-14 aryl C1-5 alkyl or C1 acyl group -6, and also the racemic, tautomeric, enantiomeric, diastereoisomeric, epimeric and polymorphic forms, and mixtures thereof, and their salts acceptable for pharmaceutical use, and one or more acceptable excipients for pharmaceutical use. |
priorityDate | 2006-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.